SCHEMBL24915979

SCHEMBL24915979

COCCN1CCN(Cc2cc(OC)cc3c(C(C)C)ccnc23)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
GAA P10253 1/20 0.40
ALDH1A1 P00352 2/20 0.40
LRRK2 Q5S007 2/20 0.40
ELANE P08246 1/20 0.39
GSK3B P49841 2/20 0.39
KDM4E B2RXH2 4/20 0.37
TP53 P04637 3/20 0.37
HTT P42858 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
USP2 O75604 1/20 0.37
ALOX15 P16050 1/20 0.37
ALOX12 P18054 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PDE1B Q01064 1/20 0.37
MAPK1 P28482 2/20 0.37
LMNA P02545 1/20 0.37
RAB9A P51151 1/20 0.37
PAX8 Q06710 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24916357 0.90 MAPT (0.47) MAPTSMN1; SMN2GAAALDH1A1KDM4E
SCHEMBL24915841 0.87 KDM4E (0.44) MAPTSMN1; SMN2GAAALDH1A1KDM4E
SCHEMBL24916132 0.85 KDM4E (0.42) MAPTSMN1; SMN2GAAALDH1A1LRRK2
SCHEMBL24916359 0.85 HTT (0.46) MAPTSMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL24915840 0.83 MTNR1B (0.46) MAPTSMN1; SMN2ALDH1A1LRRK2KDM4E
SCHEMBL24916363 0.83 ALDH1A1 (0.39) MAPTSMN1; SMN2GAAALDH1A1GSK3B
SCHEMBL24915839 0.82 LRRK2 (0.39) MAPTSMN1; SMN2GAAALDH1A1LRRK2
SCHEMBL24916364 0.81 TLR9 (0.41) MAPTSMN1; SMN2ALDH1A1LRRK2ELANE
SCHEMBL24916360 0.78 KDM4E (0.43) MAPTSMN1; SMN2GAAALDH1A1KDM4E
SCHEMBL24916365 0.78 NSD2 (0.39) MAPTSMN1; SMN2GAAKDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 MAPT 1413/4885SMN1; SMN2 2582/4885GAA 3980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.